Drug profile · INN
flurbiprofen sodium
OCUFEN
flurbiprofen sodium (OCUFEN) is a cyclooxygenase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — flurbiprofen sodium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
flurbiprofen sodium (OCUFEN) is a cyclooxygenase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is flurbiprofen sodium?
flurbiprofen sodium (OCUFEN) is a cyclooxygenase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for flurbiprofen sodium?
OCUFEN is a marketed brand name for flurbiprofen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flurbiprofen sodium?
flurbiprofen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.